I obtained my BS in General Biology from Minzu University of China, Beijing, China. After that, I went to Northwestern University, where I completed my Master’s in Biotechnology. I continued working at Northwestern after my MS for two years as a research technician. My main project involved working on the characterization of novel nitric oxide-based therapies to prevent the development of neointimal hyperplasia. In the Fall of 2016, I joined the Biological and Biomedical Sciences PhD Program at UNC – Chapel Hill. My current project focuses on using Nrf-2 activators to prevent arterial restenosis in a rat model of type 2 diabetes.